PNC Financial Services Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
N
IC
IEFM
PNC Financial Services Group's TXG Position: Q2 2026 in Review
PNC Financial Services Group increased its 10x Genomics (TXG) stake by 0.31% in Q2 2026, buying an estimated $655 and bringing the position to 8,119 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2136.
PNC Financial Services Group first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. 194 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- PNC Financial Services Group held 8,119 shares of 10x Genomics worth $311K as of Q2 2026.
- PNC Financial Services Group bought 25 10x Genomics shares in Q2 2026, an estimated $655.
- 10x Genomics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2136 holding.
- PNC Financial Services Group first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
- 194 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.